Cargando…
Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs
The genus Enterovirus combines a portion of small (+)ssRNA-containing viruses and is divided into 10 species of true enteroviruses and three species of rhinoviruses. These viruses are causative agents of the widest spectrum of severe and deadly epidemic diseases of higher vertebrates, including huma...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087576/ https://www.ncbi.nlm.nih.gov/pubmed/29523062 http://dx.doi.org/10.1134/S0006297917130041 |
_version_ | 1783509358308491264 |
---|---|
author | Nikonov, O. S. Chernykh, E. S. Garber, M. B. Nikonova, E. Yu. |
author_facet | Nikonov, O. S. Chernykh, E. S. Garber, M. B. Nikonova, E. Yu. |
author_sort | Nikonov, O. S. |
collection | PubMed |
description | The genus Enterovirus combines a portion of small (+)ssRNA-containing viruses and is divided into 10 species of true enteroviruses and three species of rhinoviruses. These viruses are causative agents of the widest spectrum of severe and deadly epidemic diseases of higher vertebrates, including humans. Their ubiquitous distribution and high pathogenici- ty motivate active search to counteract enterovirus infections. There are no sufficiently effective drugs targeted against enteroviral diseases, thus treatment is reduced to supportive and symptomatic measures. This makes it extremely urgent to develop drugs that directly affect enteroviruses and hinder their development and spread in infected organisms. In this review, we cover the classification of enteroviruses, mention the most common enterovirus infections and their clinical man- ifestations, and consider the current state of development of anti-enteroviral drugs. One of the most promising targets for such antiviral drugs is the viral Internal Ribosome Entry Site (IRES). The classification of these elements of the viral mRNA translation system is also examined. |
format | Online Article Text |
id | pubmed-7087576 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Pleiades Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-70875762020-03-23 Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs Nikonov, O. S. Chernykh, E. S. Garber, M. B. Nikonova, E. Yu. Biochemistry (Mosc) Review The genus Enterovirus combines a portion of small (+)ssRNA-containing viruses and is divided into 10 species of true enteroviruses and three species of rhinoviruses. These viruses are causative agents of the widest spectrum of severe and deadly epidemic diseases of higher vertebrates, including humans. Their ubiquitous distribution and high pathogenici- ty motivate active search to counteract enterovirus infections. There are no sufficiently effective drugs targeted against enteroviral diseases, thus treatment is reduced to supportive and symptomatic measures. This makes it extremely urgent to develop drugs that directly affect enteroviruses and hinder their development and spread in infected organisms. In this review, we cover the classification of enteroviruses, mention the most common enterovirus infections and their clinical man- ifestations, and consider the current state of development of anti-enteroviral drugs. One of the most promising targets for such antiviral drugs is the viral Internal Ribosome Entry Site (IRES). The classification of these elements of the viral mRNA translation system is also examined. Pleiades Publishing 2018-01-03 2017 /pmc/articles/PMC7087576/ /pubmed/29523062 http://dx.doi.org/10.1134/S0006297917130041 Text en © Pleiades Publishing, Ltd. 2017 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Nikonov, O. S. Chernykh, E. S. Garber, M. B. Nikonova, E. Yu. Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs |
title | Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs |
title_full | Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs |
title_fullStr | Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs |
title_full_unstemmed | Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs |
title_short | Enteroviruses: Classification, diseases they cause, and approaches to development of antiviral drugs |
title_sort | enteroviruses: classification, diseases they cause, and approaches to development of antiviral drugs |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087576/ https://www.ncbi.nlm.nih.gov/pubmed/29523062 http://dx.doi.org/10.1134/S0006297917130041 |
work_keys_str_mv | AT nikonovos enterovirusesclassificationdiseasestheycauseandapproachestodevelopmentofantiviraldrugs AT chernykhes enterovirusesclassificationdiseasestheycauseandapproachestodevelopmentofantiviraldrugs AT garbermb enterovirusesclassificationdiseasestheycauseandapproachestodevelopmentofantiviraldrugs AT nikonovaeyu enterovirusesclassificationdiseasestheycauseandapproachestodevelopmentofantiviraldrugs |